Johnson & Johnson (JNJ) Tops Q1 EPS by 19c; adjusts forecast
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $260.12 -0.28%
Financial Fact:
Interest expense, net of portion capitalized: 192M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest expense, net of portion capitalized: 192M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
(Updated - April 15, 2025 6:41 AM EDT)
Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.77, $0.19 better than the analyst estimate of $2.58. Revenue for the quarter came in at $21.89 billion versus the consensus estimate of $21.57 billion.
GUIDANCE:
Johnson & Johnson sees FY2025 EPS of $10.50-$10.70, versus the consensus of $10.50. JNJ sees FY2025 operational sales guidance at $92 billion at the midpoint, versus the consensus of $90.3 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Popular stocks: SPCX INTC MU SMCI NFLX CRWV PLTR CSCO NBIS NOK ORCL HOOD
- Freedom Broker Double Downgrades Mosaic (MOS) to Sell
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
